MB

NFI announces Election of Directors, including new Board member Anne Marie O’Donovan

Retrieved on: 
Monday, May 6, 2024
Chairperson, Audit committee, Workplace, NFI

“I’m pleased to welcome Anne Marie O’Donovan to our Board, whose expertise in finance and public company governance will be a tremendous addition not only as a director, but also as Chair of our Audit Committee,” said Ms. Wendy Kei, Chair of the Board.

Key Points: 
  • “I’m pleased to welcome Anne Marie O’Donovan to our Board, whose expertise in finance and public company governance will be a tremendous addition not only as a director, but also as Chair of our Audit Committee,” said Ms. Wendy Kei, Chair of the Board.
  • “Looking to the remainder of fiscal 2024 and into the longer-term, NFI is very well positioned to benefit from record investments in public transportation, the transition to zero-emission mobility, and its solid market position and backlog.
  • Our Board remains extremely confident in NFI’s management team and will continue to play an active role in overseeing the Company’s recovery as it delivers on its sustainability pledge to deliver a better product, a better workplace and a better world.”

NFI announces first quarter 2024 results

Retrieved on: 
Thursday, May 2, 2024
Conversation, Investment, Risk, Webcast, Growth, EST, NFI, Financial statement, FCA, Documentation, Audit committee, Net, Executive, American Public Transportation Association, Net operating assets, Travel, FCPA, Public expenditure, ICD, LTM, Government, Ernst & Young, ZEB, Fiscal, Eus, History, Senior, Appendix, Bank statement, Scotiabank, WIP

WINNIPEG, Manitoba, May 02, 2024 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. ("NFI" or the "Company"), a leader in zero-emission electric mobility solutions, today announced its unaudited interim condensed consolidated financial results for the first quarter of 2024.

Key Points: 
  • Results noted herein are for the 13-week period ("2024 Q1”) and the 52-week period ("2024 Q1 LTM”) ended March 31, 2024.
  • NFI generated $10 million in cash flows from working capital in the first quarter of 2024, as higher vehicle deliveries lowered finished goods and work-in-process (“WIP”) inventory.
  • NFI anticipates that nearly all of the remaining legacy inflation-impacted contracts will be delivered during the second quarter of 2024.
  • NFI reiterates its previously provided financial guidance for Fiscal 2024 and targets for 2025 as disclosed on January 17, 2024.

NFI schedules first quarter 2024 financial results and Annual Meeting of Shareholders

Retrieved on: 
Wednesday, April 17, 2024
Webcast, OTC, TSX, NFI, Eastern Time Zone

NFI encourages attendees to join via webcast as a results presentation will be presented and users can also submit questions to management through the platform.

Key Points: 
  • NFI encourages attendees to join via webcast as a results presentation will be presented and users can also submit questions to management through the platform.
  • NFI’s Annual Meeting of Shareholders (the “Shareholders’ Meeting”) will be held virtually on Friday, May 3, 2024, at 11:00 a.m.
  • The materials for the Shareholders’ Meeting and voting instructions will be sent to shareholders in advance of the meeting.
  • Details on how to join the meeting, along with other relevant documents, including the Management Information Circular, have been posted on NFI’s website at: https://www.nfigroup.com/events-and-presentation/annual-general-meeting .

Kane Biotech to Host Investor Webinar

Retrieved on: 
Tuesday, April 16, 2024
Acne, Sale, CND, KNE

WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern Time.

Key Points: 
  • WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern Time.
  • Marc Edwards, Kane's President & CEO, will share his thoughts on what the sale of STEM Animal Health, which should ultimately net Kane more than $13 million CND, means for Kane as an important step in becoming a market leader in the growing high-value wound care and dermatological markets.
  • The transaction, which focuses the company and significantly improves the balance sheet, will provide the necessary capital to achieve key milestones such as commercial launches and global growth, as well as our clinical programs in both wound care and acne.

Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products

Retrieved on: 
Monday, April 15, 2024
Sale, Non, CND, Partnership, Transaction, KNE, TSX Venture Exchange, Growth, Bank

Overall, it is anticipated that the sale of STEM will net Kane an estimated CND $11,500,000.

Key Points: 
  • Overall, it is anticipated that the sale of STEM will net Kane an estimated CND $11,500,000.
  • The Transaction was completed by way of a share purchase agreement between Kane, STEM, Ecuphar NV and Dechra dated April 12, 2024.
  • In connection with the Transaction, Kane also entered into a product development agreement, and a transitional manufacturing agreement with STEM.
  • In connection with the completion of the Transaction, Kane obtained the written consent of shareholders of Kane holding more than 50% of the common shares of Kane.

Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health

Retrieved on: 
Thursday, April 11, 2024
Sale, CND, Health, Transaction, Biotechnology, KNE, TSX Venture Exchange, Interest

Overall, it is anticipated that the sale of STEM Animal Health will net Kane Biotech in excess of CND $11,500,000 (including the cash deposits already received, as noted below).

Key Points: 
  • Overall, it is anticipated that the sale of STEM Animal Health will net Kane Biotech in excess of CND $11,500,000 (including the cash deposits already received, as noted below).
  • The Purchaser is not a Non-Arm’s Length Party (as that term is defined by the TSX Venture Exchange) of the Company.
  • “We are pleased with the outcome of this transaction,” said Marc Edwards, President & CEO of Kane Biotech.
  • “Kane Biotech will be receiving full value for the successful animal health business that it created allowing the Company to significantly strengthen its balance sheet and narrow its focus on human health biofilm solutions.”
    Prior to the completion of the Transaction, the Company owned a 2/3 interest in STEM.

The North West Company Inc. Announces Fourth Quarter Earnings and a Quarterly Dividend

Retrieved on: 
Wednesday, April 10, 2024
GAAP, Social, Depreciation, Modern Slavery Act 2015, Sustainability, Health, Interest, Biophysical environment, Expense, Administration, Tax, Income tax, ESG, CUL, Ratio, Child, Quality of life, Bank

Consolidated Fourth Quarter Sales Sales for the quarter increased 1.3% to $643.1 million led by same store sales gains in Canadian Operations and the impact of new stores in Canadian and International Operations.

Key Points: 
  • Consolidated Fourth Quarter Sales Sales for the quarter increased 1.3% to $643.1 million led by same store sales gains in Canadian Operations and the impact of new stores in Canadian and International Operations.
  • Net Earnings Consolidated net earnings increased $0.9 million or 2.5% to $36.0 million compared to $35.1 million last year.
  • Earnings from Operations (EBIT) and EBITDA(1) Earnings from operations or earnings before interest and income taxes ("EBIT”) increased 8.6% to $195.9 million compared to $180.3 million last year.
  • (1) Earnings Before Interest, Income Taxes, Depreciation and Amortization (EBITDA), Adjusted EBITDA and Adjusted Net Earnings are not recognized measures under IFRS.

Hoot Reading Celebrates Success of BlueCare Tennessee Sponsored Reading Program

Retrieved on: 
Wednesday, March 27, 2024
Partnership, Student, School, Hoot, Literacy, Entrepreneurship, Tutoring

Hoot Reading's impactful online literacy tutoring programs, generously sponsored by BlueCare Tennessee, will continue empowering students and bridging gaps in their reading journeys.

Key Points: 
  • Hoot Reading's impactful online literacy tutoring programs, generously sponsored by BlueCare Tennessee, will continue empowering students and bridging gaps in their reading journeys.
  • "The success of enrollment one at Double Tree Elementary, sponsored by BlueCare Tennessee, is a testament to Hoot Reading's mission to change students' lives through literacy," said Carly Shuler, Co-Founder and Co-CEO of Hoot Reading.
  • "We extend our gratitude to Hoot Reading and BlueCare Tennessee for sponsoring the program at Double Tree Elementary," said Principal Jacqueline Brown.
  • The support from Hoot Reading and BlueCare Tennessee is invaluable, and we look forward to positive outcomes in our students' reading skills."

Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, March 26, 2024
Diabetic foot, Financial statement, PIN, Ulcer, Symposium, Sale, KNE, Pivot, Credit, Leg, SAWC, US FDA, Patent, FDA, Government, Food

WINNIPEG, Manitoba, March 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its fourth quarter and full year 2023 financial results.

Key Points: 
  • WINNIPEG, Manitoba, March 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its fourth quarter and full year 2023 financial results.
  • On December 20, 2023, Kane Biotech announced that it received a non-binding offer for its interest in STEM Animal Health.
  • Gross profit for the fourth quarter of 2023 was $398,234, an increase of 24% compared to $320,653 for the fourth quarter ended December 31, 2022.
  • Loss for the fourth quarter of 2023 was ($1,611,894), an increase of 92% compared to ($838,150) for the quarter ended December 31, 2022.

The North West Company Inc. Fourth Quarter Results and Conference Call

Retrieved on: 
Friday, March 22, 2024
Giant, Name, Central Time, The North West Company, CAD, Food, Giant Tiger, Alaska Commercial Company

WINNIPEG, Manitoba, March 22, 2024 (GLOBE NEWSWIRE) -- (TSX Symbol: NWC): The North West Company Inc. (“North West”) will host a conference call for its fourth quarter results on April 10, 2024 at 1:30 p.m. (Central Time).

Key Points: 
  • WINNIPEG, Manitoba, March 22, 2024 (GLOBE NEWSWIRE) -- (TSX Symbol: NWC): The North West Company Inc. (“North West”) will host a conference call for its fourth quarter results on April 10, 2024 at 1:30 p.m. (Central Time).
  • The North West Company Inc., through its subsidiaries, is a leading retailer of food and everyday products and services to rural communities and urban neighbourhoods in Canada, Alaska, the South Pacific and the Caribbean.
  • North West operates 227 stores under the trading names Northern, NorthMart, Giant Tiger, Alaska Commercial Company, Cost-U-Less and RiteWay Food Markets and has annualized sales of approximately CAD $2.4 billion.
  • For further information, please contact: John King, Chief Financial Officer of The North West Company Inc. at (204) 934-1397, email [email protected] .